In the past few years, the mechanisms that integrate the Ras-RAF-MEK-ERK pathway into the bladder cancer phenotypes have started to accumulate, including a subset of bladder tumors with focal amplifications of RAF1 gene, and found that these amplifications drive activation of the canonical MAPK pathway (14). This evidence concerns the gene RAF1 and urinary bladder cancer.